Drugs / Levovist
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00222040 | Jun 2004 | ischemic stroke | University Hospital, Toulouse | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Levovist | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00222040 ↗ |
| Route | Intravenous | “Galactose-based microbubbles are administered via continuous intravenous infusion over 40 min.” NCT00222040 ↗ |